James Campbell

James Campbell

78 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

James N.
Campbell
is the founder of Centrexion Therapeutics Corp., founded in 2013, where the titles held include President, Chief Scientific Officer & Director.
Dr. Campbell was the founder of Arcion Therapeutics LLC, founded in 2007, where the titles held included President & Chief Executive Officer.
Dr. Campbell is also the founder of Amplimmune, Inc.,American Pain Foundation, Inc...
Dr. Campbell is Chief Executive Officer at Vallinex, Inc. Dr. Campbell is Director at CNS Therapeutics, Inc. Dr. Campbell is Neurosurgery Professor at The Johns Hopkins University.
Dr. Campbell was Director at Anesiva, Inc. from 2007 to 2008.
Dr. Campbell was Director at Detroit Trading Co. Dr. Campbell was President at American Pain Society.
Dr. Campbell was Executive-in-Residence at InterWest Venture Management Co. Dr. Campbell earned a doctorate from Yale University.
Dr. Campbell completed undergraduate studies at the University of Michigan.

Aktive Positionen von James Campbell

UnternehmenPositionBeginn
CENTREXION THERAPEUTICS CORPORATION Gründer 01.02.2013
Corporate Officer/Principal -
Direktor/Vorstandsmitglied 29.11.2010
Vorstandsvorsitzender 19.01.2012

Ehemalige bekannte Positionen von James Campbell

UnternehmenPositionEnde
Direktor/Vorstandsmitglied 19.12.2008
Präsident -
Direktor/Vorstandsmitglied -
Gründer -
Gründer -
Sehen Sie sich die Erfahrung von James Campbell im Detail an

Ausbildung von James Campbell

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

88

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Finance

Technology Services

Health Technology

  1. Börse
  2. Insiders
  3. James Campbell